NextPoint Therapeutics, Inc.
New Filing
CIK: 0001959209·Biotechnology·DELAWARE·Filed: Jul 30, 2026
Total Offering
$48,729,165
Amount Sold
$33,728,772
Investors
15
First Sale
Jul 22, 2026
Offering Details
- Type
- Equity, Option to Acquire
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Detlev Biniszkiewicz | |
| Ivan Cheung | |
| Axel Hoos | |
| R. Jacob Vogelstein | |
| Brian Shuster | |
| Paulina Hill | |
| Rakhshita Dhar | |
| Jeffrey Lacey |
Company
SEC Filing
0001959209-26-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free